Healthcare and Life Sciences Leaders Build on NVIDIA to Advance Drug Discovery and Expand Patient Care
NVIDIA today announced collaborations with leading global healthcare and research organizations to advance protein design — including through a newly released open model, RFD4-Proteina — accelerate drug discovery and bring greater precision to cancer care.
Why it matters
Open the original announcement for availability, limitations and the publisher’s supporting evidence.
Publisher announcement from NVIDIA Newsroom. Publisher claims are not independently verified.
Open in today’s briefing →